search
Back to results

Expanded Access for Anti-IL8

Primary Purpose

Status
No longer available
Phase
Locations
Study Type
Expanded Access
Intervention
Anti-IL8
Sponsored by
Bristol-Myers Squibb
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an expanded access trial

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)

Sites / Locations

    Outcomes

    Primary Outcome Measures

    Secondary Outcome Measures

    Full Information

    First Posted
    November 16, 2021
    Last Updated
    May 10, 2022
    Sponsor
    Bristol-Myers Squibb
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05210894
    Brief Title
    Expanded Access for Anti-IL8
    Study Type
    Expanded Access

    2. Study Status

    Record Verification Date
    May 2022
    Overall Recruitment Status
    No longer available
    Study Start Date
    undefined (undefined)
    Primary Completion Date
    undefined (undefined)
    Study Completion Date
    undefined (undefined)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Bristol-Myers Squibb

    4. Oversight

    5. Study Description

    Brief Summary
    This is an expanded access designed to provide access to Anti-IL8 for eligible participants.

    6. Conditions and Keywords

    7. Study Design

    8. Arms, Groups, and Interventions

    Intervention Type
    Biological
    Intervention Name(s)
    Anti-IL8

    10. Eligibility

    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Bristol-Myers Squibb
    Organizational Affiliation
    Bristol-Myers Squibb
    Official's Role
    Study Director

    12. IPD Sharing Statement

    Links:
    URL
    https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html
    Description
    BMS Clinical Trial Information
    URL
    https://www.bmsstudyconnect.com/s/US/English/USenHome
    Description
    BMS Clinical Trial Patient Recruiting
    URL
    https://www.bms.com/healthcare-providers/early-patient-access-to-investigational-medicine/investigational-drugs-available.html
    Description
    Pre-Approval Access (PAA) Healthcare Practitioner Requests
    URL
    https://www.fda.gov/Safety/MedWatch/SafetyInformation/default.htm
    Description
    FDA Safety Alerts and Recalls

    Learn more about this trial

    Expanded Access for Anti-IL8

    We'll reach out to this number within 24 hrs